Auna (AUNA) Stock Price

Auna Price

CLOSED
15.56
​
Market closed

Revenue has compounded at 25.3% per year over the past 8 years to 4.39 B PEN. Earnings per share have grown at 34.8% per year over the last 8 years. Auna's net margin stands at 2.2%, up from -1.4% several years earlier. Analysts set a median price target of 31.20 PEN, implying 100.5% above the current price. Of 14 analysts, 11 rate the stock a buy — an overall Buy consensus.

Auna stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Auna business model & stock analysis

Auna SA generates revenue through prepaid healthcare plans, medical care services, and oncology solutions provided to patients within its integrated healthcare system. The company operates a network of nearly 31 healthcare facilities across Luxembourg, Mexico, Peru, and Colombia, including hospitals, clinics, outpatient centers, and wellness facilities with a total of 2,308 beds. Its patient-centric model emphasizes prevention, research, and education to promote healthy lifestyles and improve patient outcomes. The company serves individuals seeking comprehensive healthcare services through its regional network of facilities. Auna SA's offerings include standard medical services delivered through its extensive network of healthcare facilities, which supports both routine care and specialized oncology treatments. The firm focuses on integrated care delivery, combining preventive measures with clinical services to enhance patient experiences. Its business model targets patients requiring accessible, holistic healthcare solutions across multiple countries. The company's revenue streams are derived from the provision of healthcare services to patients within its network, leveraging its 2,308-bed capacity across 31 facilities. Auna SA's model integrates prevention, research, and education to support healthy lifestyles, creating value for patients through comprehensive care pathways. Its presence in Luxembourg, Mexico, Peru, and Colombia enables it to serve diverse patient populations with varying healthcare needs.

Frequently asked questions about Auna

Analysts currently set an average price target of 41.33 PEN for the Auna stock (median: 31.20 PEN), implying +164.3 % versus the latest price. The consensus is based on 14 analyst ratings.

14 analysts currently rate the Auna stock: 11 recommend buying, 3 holding and 0 selling. For 2026, analysts expect Auna to generate revenue of 4.96 B PEN and earnings per share of 6.46 PEN.

Converted at the current exchange rate, the Auna share trades at 4.01 EUR (15.56 PEN).

The expected revenue of Auna is 4.96 B PEN. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Auna is 194.30 M PEN. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Auna is currently 2.41. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Auna stock.

The price-to-sales ratio (P/S) of Auna is currently 0.09. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Auna stock.

The Eulerpool Quality Score for Auna is 4/10.

The ISIN of Auna is LU2791994721. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Auna is AUNA. The ticker symbol is used to trade Auna shares on the stock exchange.

Fair ValueTerminal
13.85 PEN
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
287,485.12 PEN
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
Luxembourg
Currency
PEN
Initial public offering
Mar 22, 2024
ISIN
LU2791994721
Cusip
05151V107
Market capitalization
1.15 B PENSmall Cap
52-Week Range
PEG
0.39
P/E ratio
P/Ee 2026
5.92
P/Ee 2027
4.50
P/Ee 2028
3.56
P/Ee 2029
3.57
P/Ee 2030
3.31
P/S
P/Se
0.09
EV/EBIT
7.08
P/B Ratio
0.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.86 %
Last updated Nov 5, 2026, 3:35 AM

Auna Peer Group

All fundamentals and in-depth analysis of Auna

Our stock analysis for Auna stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Auna. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.